CVKD
Cadrenal Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.06
−2.75%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.91
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.14
- EPS estimate
- -$1.42
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +0.7%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$1.42 | -$1.14 | Beat 19.72% | — |
| May 7, 2026 | -$1.51 | -$1.04 | Beat 31.13% | — |
| Mar 31, 2026 | -$1.17 | -$1.41 | Miss -20.51% | — |
| May 8, 2025 | -$1.64 | -$2.09 | Miss -27.44% | — |
| Mar 13, 2025 | -$1.71 | -$2.74 | Miss -60.23% | $2.1K |
| Nov 7, 2024 | -$1.83 | -$2.18 | Miss -19.13% | — |
| May 9, 2024 | -$1.05 | -$1.50 | Miss -42.86% | — |
| Mar 11, 2024 | -$1.35 | -$0.75 | Beat 44.44% | $2.8K |
| Nov 9, 2023 | -$1.05 | -$1.05 | In line | — |
| Aug 10, 2023 | — | -$1.35 | — | — |
| Jun 30, 2022 | — | -$0.04 | — | — |
| Mar 31, 2022 | — | -$0.02 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026